Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Biology International|June 15, 2004
ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agentWilli Woessmann, Dorothea Zwanzger, Arndt Borkhardt
Cancer Chemotherapy and Pharmacology|November 20, 2002
Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell linesWilli Woessmann, Xinbin Chen, Arndt Borkhardt
Reviews in Clinical and Experimental Hematology|March 18, 2004
RNA interference: new mechanisms for targeted treatment?Willi Woessmann, Christine Damm-Welk, Uta Fuchs, et al.
Transfusion|November 12, 2009
Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindicationsHolger Hackstein, Joachim Misterek, Angelika Nockher, et al.
Klinische Padiatrie|April 21, 2020
[Registries and studies in the Society for Pediatric Oncology and Hematology (GPOH) - What contribution do they make to progress?]Thomas Klingebiel, Heribert Jürgens, Ingmar Glauche, et al.
British Journal of Haematology|June 24, 2009
Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlationChristine Damm-Welk, Wolfram Klapper, Ilske Oschlies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group studyWilli Woessmann, Martin Zimmermann, Meike Lenhard, et al.
British Journal of Haematology|November 15, 2014
Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study groupUdo Kontny, Ilske Oschlies, Willi Woessmann, et al.
Pageof 2